Sutro Biopharma

STRONasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$254.355 M

$15.34 -0.90%

Close of 18 Sept 2026

Revenue

$102.5M

#2493 by revenue

Earnings

-$191.0M

Loss-making

Shares outstanding

16,581,171

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 159 →

#86Palisade BioPALI$277.1M
#87Lineage Cell TherapeuticsLCTX$260.5M
#88Sutro BiopharmaSTRO$254.4M
#89CompugenCGEN$235.5M
#90Cardiol TherapeuticsCRDL$226.2M

What if Sutro Biopharma were worth as much as…

Open the what-if tool →

Gold $30.4T

$1,832,649

Per share 119,469× higher

Bitcoin $1.64T

$98,667.81

Per share 6,432× higher

Nvidia $5.36T

$323,059.63

Per share 21,060× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Sutro Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.